Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |